Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.00
Bid: 61.20
Ask: 63.20
Change: 1.00 (1.64%)
Spread: 2.00 (3.268%)
Open: 63.00
High: 63.40
Low: 61.20
Prev. Close: 61.00
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Awards - Performance Share Plan

7 Jun 2017 14:26

RNS Number : 4447H
Renold PLC
07 June 2017
 

Renold plc

("Renold" or "the Company")

 

GRANT OF AWARDS - PERFORMANCE SHARE PLAN

 

Renold announces that nil cost options (the "Awards") were granted on 5 June 2017 under the 2013 Performance Share Plan to the Executive Directors of the Company.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

The number of shares under the Awards was based on the average mid-market price for the preceding three days which was 54.79 pence.

The performance period applicable to the Awards is 1 April 2017 to 31 March 2020.

Robert Purcell (Chief Executive Officer)

 

Nil cost options over 1,095,090 shares were granted. The performance criteria for the vesting of the award is as follows. There are two performance targets.

 

EPS target attached to 50% of the award as follows:

 

Compound Annual Growth Rate in adjusted earnings per share ('adjusted EPS').

 

Entry level threshold - 25% of awards vest

10%

Maximum vesting - 100% of awards vest

15%

 

Between these two points the award vests on a linear basis. The starting measurement point is the adjusted EPS figure for the year ended 31 March 2017.

Provided that the minimum EPS target is achieved, a TSR target is attached to 50% of the award as follows:

 

TSR at the end of the Performance Period

% of Part B of Option that Vests

0%

83.9p

25%

Between 83.9p and 109.9p

25%-100% pro-rata

109.9p

100%

 

 

Ian Scapens (Group Finance Director)

Nil cost options over 337,653 shares were granted. The performance criteria for the vesting of the award is as follows:

 

Compound Annual Growth Rate in adjusted earnings per share ('adjusted EPS').

 

Entry level threshold - 25% of awards vest

10%

Maximum vesting - 100% of awards vest

15%

 

Between these two points the award vests on a linear basis. The starting measurement point is the adjusted EPS figure for the year ended 31 March 2017.

5 June 2017

ENQUIRIES:

Renold plc

0161 498 4500

Robert Purcell, Chief Executive Officer

 

Ian Scapens, Group Finance Director

 

 

 

Arden Partners

020 7614 5929

Chris Hardie

 

 

 

Instinctif

020 7457 2020

Mark Garraway

 

Helen Tarbet

 

NOTES FOR EDITORS

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

Further information about Renold can be found on its website at: www.renold.com

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Purcell

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

b)

LEI

213800LNDGJY65SP6P54

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Nil cost options over Ordinary Shares of £0.05

 

ISIN: GB0007325078

 

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Nil Cost Options

1,095,090

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

5 June 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Scapens

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

b)

LEI

213800LNDGJY65SP6P54

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Nil cost options over Ordinary Shares of £0.05

 

ISIN: GB0007325078 

 

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Nil Cost Options

337,653

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

5 June 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUBUORBSANRAR
Date   Source Headline
6th Nov 200710:23 amRNSAlstom Contract Award
1st Nov 20077:00 amRNSTotal Voting Rights
17th Oct 200710:09 amRNS2007/2008 H1 Results Date
28th Sep 20079:06 amRNSTotal Voting Rights
26th Sep 200711:45 amRNSDirector/PDMR Shareholding
10th Sep 200712:54 pmRNSAdditional Listing
7th Sep 200710:20 amRNSAnnual Information Update
31st Aug 20077:01 amRNSTotal Voting Rights
30th Aug 200711:58 amRNSDirector/PDMR Shareholding
29th Aug 200712:48 pmRNSDirector/PDMR Shareholding
8th Aug 20073:25 pmRNSDirector/PDMR Shareholding
8th Aug 20071:26 pmRNSHolding(s) in Company
1st Aug 20075:44 pmRNSNED appointment
31st Jul 20073:57 pmRNSBlocklisting Interim Review
31st Jul 20073:54 pmRNSBlocklisting Interim Review
31st Jul 20071:17 pmRNSTotal Voting Rights
31st Jul 20079:18 amRNSHolding(s) in Company
31st Jul 20079:16 amRNSDirector/PDMR Shareholding
26th Jul 20074:58 pmRNSDirector/PDMR Shareholding
26th Jul 20072:38 pmRNS2007 AGM Resolutions
26th Jul 20077:14 amRNSInterim Management Statement
13th Jul 20078:45 amRNSDirector/PDMR Shareholding
12th Jul 20072:46 pmRNSDirectorships
10th Jul 20078:56 amRNSDirector/PDMR Shareholding
29th Jun 200712:13 pmRNSDirector/PDMR Shareholding
26th Jun 20075:39 pmRNSHolding(s) in Company
26th Jun 20075:34 pmRNSDirector/PDMR Shareholding
26th Jun 200712:51 pmRNSDirector's share purchase
26th Jun 20079:34 amRNSBurton planning consent
25th Jun 200711:06 amRNSDirector's share purchase
25th Jun 20077:01 amRNSFinal Results
18th Jun 20077:00 amRNSCompletion of acquisition
5th Jun 200712:16 pmRNSNotice of Results
1st Jun 200710:49 amRNSHolding(s) in Company
1st Jun 200710:45 amRNSHolding(s) in Company
1st Jun 200710:37 amRNSTotal Voting Rights
21st May 20077:03 amRNSAcquisition
16th May 200711:33 amRNSHolding(s) in Company
16th May 200711:30 amRNSHolding(s) in Company
15th May 200710:48 amRNSHolding(s) in Company
15th May 200710:44 amRNSHolding(s) in Company
30th Apr 20075:02 pmRNSTotal Voting Rights
30th Apr 20077:01 amRNSChange of Adviser
2nd Apr 20074:53 pmRNSTotal Voting Rights
29th Mar 20071:59 pmRNSHolding(s) in Company
29th Mar 20071:56 pmRNSHolding(s) in Company
27th Mar 200710:48 amRNSHolding(s) in Company
21st Mar 200710:03 amRNSHolding(s) in Company
19th Mar 200711:56 amRNSHolding(s) in Company
14th Mar 20073:17 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.